RHUMBLINE ADVISERS - PHASEBIO PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 53 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$36,000
+2.9%
10,4920.0%0.00%–
Q4 2020$35,000
-36.4%
10,492
-12.1%
0.00%–
Q2 2020$55,000
+31.0%
11,932
+17.2%
0.00%–
Q3 2019$42,000
-68.9%
10,182
-1.2%
0.00%–
Q2 2019$135,000–10,307–0.00%–
 Download
Other shareholders

There were no reported owners of PHASEBIO PHARMACEUTICALS INC in Q2 2019.

NameSharesValueWeighting ↓
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders